According to Bharat Biotech, Covaxin is formulated uniquely such that the same dosage can be administered to adults and children alike, for primary and booster doses, making it a universal vaccine. Bharat Biotech on Friday announced that Japan has approved the Covaxin booster dose for travellers. "We are proud to announce, that Japan has approved Covaxin booster dose for travellers. Another global recognition of the effectiveness of our universal Covid vaccine," Bharat Biotech tweeted. Quarantine Station of Japan's Ministry of Health, Labour and Welfare issued an advisory for the Quarantine period after entering Japan to Japan from countries/regions categorized as "RED" in border control measures(28) and who have not had three doses of a Covid-19 vaccination will be required to quarantine for three days at accommodations designated by a quarantine station." It further said that the travellers will not be required to quarantine after leaving the facility if the results of a test taken at the accommodations are negative. "Travelers who are entering or returning to Japan from countries/regions categorized as "RED" in border control measures(28) and who have a certificate confirming they have received three vaccination doses will be required to quarantine at home/accommodations of their choosing for five days, in principle." "However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that," the statement added. The statement also said that "Travelers who are entering or returning to Japan from countries/regions categorised as "YELLOW" in border control measures(28) and have not received three vaccination doses will be required to quarantine at home/accommodations of their choosing for five days, in principle." "However, if they take a self-test after three days after entering Japan and submit a negative result to the Ministry of Health, Labour and Welfare (Health Monitoring Center for Overseas Entrants, or HCO) where its status is confirmed, they will not be required to remain in quarantine after that
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!